DrugCite
Search

HUMULIN L

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Humulin L Adverse Events Reported to the FDA Over Time

How are Humulin L adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Humulin L, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Humulin L is flagged as the suspect drug causing the adverse event.

Most Common Humulin L Adverse Events Reported to the FDA

What are the most common Humulin L adverse events reported to the FDA?

Blood Glucose Increased
55 (7.02%)
Blood Glucose Decreased
41 (5.23%)
Blood Glucose Fluctuation
20 (2.55%)
Loss Of Consciousness
19 (2.42%)
Drug Ineffective
17 (2.17%)
Hypoglycaemia
14 (1.79%)
Myocardial Infarction
14 (1.79%)
Cardiac Disorder
12 (1.53%)
Cerebrovascular Accident
12 (1.53%)
Asthenia
9 (1.15%)
Feeling Abnormal
9 (1.15%)
Show More Show More
Hypoglycaemia Unawareness
9 (1.15%)
Visual Acuity Reduced
8 (1.02%)
Diabetic Ketoacidosis
7 (.89%)
Dizziness
7 (.89%)
Drug Hypersensitivity
7 (.89%)
Fall
7 (.89%)
Lower Limb Fracture
7 (.89%)
Vomiting
7 (.89%)
Cataract
6 (.77%)
Diabetes Mellitus Inadequate Contro...
6 (.77%)
Drug Interaction
6 (.77%)
Malaise
6 (.77%)
Oedema Peripheral
6 (.77%)
Osteoporosis
6 (.77%)
Arthralgia
5 (.64%)
Blindness
5 (.64%)
Drug Exposure During Pregnancy
5 (.64%)
Ketoacidosis
5 (.64%)
Medication Error
5 (.64%)
Poor Quality Drug Administered
5 (.64%)
Road Traffic Accident
5 (.64%)
Tremor
5 (.64%)
Weight Decreased
5 (.64%)
Burning Sensation
4 (.51%)
Cardiac Failure Congestive
4 (.51%)
Convulsion
4 (.51%)
Decreased Appetite
4 (.51%)
Depression
4 (.51%)
Diarrhoea
4 (.51%)
Fatigue
4 (.51%)
Glycosylated Haemoglobin Increased
4 (.51%)
Insomnia
4 (.51%)
Mobility Decreased
4 (.51%)
Renal Failure Chronic
4 (.51%)
Weight Increased
4 (.51%)
Anaphylactic Shock
3 (.38%)
Ankle Fracture
3 (.38%)
Anxiety
3 (.38%)
Blindness Unilateral
3 (.38%)
Blood Cholesterol Increased
3 (.38%)
Blood Pressure Increased
3 (.38%)
Chest Pain
3 (.38%)
Coma
3 (.38%)
Cystitis
3 (.38%)
Dehydration
3 (.38%)
Drug Intolerance
3 (.38%)
Gastric Disorder
3 (.38%)
Hypersensitivity
3 (.38%)
Hypoglycaemic Coma
3 (.38%)
Hypoglycaemic Seizure
3 (.38%)
Limb Injury
3 (.38%)
Macular Degeneration
3 (.38%)
Nausea
3 (.38%)
Nervousness
3 (.38%)
Pain
3 (.38%)
Pancreatic Disorder
3 (.38%)
Paraesthesia Oral
3 (.38%)
Psychomotor Hyperactivity
3 (.38%)
Renal Failure
3 (.38%)
Retinal Haemorrhage
3 (.38%)
Viral Infection
3 (.38%)
Vision Blurred
3 (.38%)
Abdominal Distension
2 (.26%)
Abdominal Pain Upper
2 (.26%)
Amputation
2 (.26%)
Anaemia
2 (.26%)
Back Disorder
2 (.26%)
Back Pain
2 (.26%)
Carpal Tunnel Syndrome
2 (.26%)
Chronic Obstructive Pulmonary Disea...
2 (.26%)
Cognitive Disorder
2 (.26%)
Cold Sweat
2 (.26%)
Dawn Phenomenon
2 (.26%)
Depressed Level Of Consciousness
2 (.26%)
Device Failure
2 (.26%)
Diabetic Complication
2 (.26%)
Diabetic Retinopathy
2 (.26%)
Drug Effect Decreased
2 (.26%)
Dry Mouth
2 (.26%)
Eating Disorder
2 (.26%)
Exostosis
2 (.26%)
Eye Haemorrhage
2 (.26%)
Failure Of Implant
2 (.26%)
Fear
2 (.26%)
Feeling Jittery
2 (.26%)
Food Allergy
2 (.26%)
General Physical Health Deteriorati...
2 (.26%)
Heart Rate Increased
2 (.26%)
Hernia
2 (.26%)
Hip Arthroplasty
2 (.26%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Humulin L, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Humulin L is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Humulin L

What are the most common Humulin L adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Humulin L, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Humulin L is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Humulin L According to Those Reporting Adverse Events

Why are people taking Humulin L, according to those reporting adverse events to the FDA?

Diabetes Mellitus
299
Diabetes Mellitus Insulin-dependent
28
Diabetes Mellitus Non-insulin-depen...
4
Drug Use For Unknown Indication
3
Type 2 Diabetes Mellitus
2
Type 1 Diabetes Mellitus
2
Show More Show More
Product Used For Unknown Indication
1
Pancreatic Disorder
1

Humulin L Case Reports

What Humulin L safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Humulin L. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Humulin L.